Nuvilex, Inc. a Biotech Developing Treatments for Healthcare's Hard Targets
26 juin 2013 08h30 HE
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Jun 26, 2013) - Nuvilex, Inc. (OTCQB: NVLX) executives aren't daunted by the statistics. As a matter of fact, they're aware the research they do is directed...
Nuvilex, Inc.'s Phase III Pancreatic Cancer Trials Could Address New Law's Call for Progress
24 juin 2013 08h30 HE
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Jun 24, 2013) - Nuvilex, Inc. (OTCQB: NVLX) has a great opportunity to demonstrate and showcase its encapsulation technology in its upcoming Phase III clinical trials...
Nuvilex, Inc.'s Medical Marijuana Subsidiary Will Be Part of Marijuana Research Boom
18 juin 2013 08h30 HE
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Jun 18, 2013) - Nuvilex, Inc.'s (OTCQB: NVLX) subsidiary, Medical Marijuana Sciences, Inc., has already declared its focus will be on pancreatic cancer and cancers...
Nuvilex, Inc.'s Cell Encapsulation Could Play Role in Multimodality Treatment of Cancer Patients
06 juin 2013 08h30 HE
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Jun 6, 2013) - Nuvilex, Inc. (OTCQB: NVLX) has a technology in its cell encapsulation process that will very likely play some role in the future of oncology. How...
Nuvilex, Inc.'s Medical Marijuana Research May Enhance Its Diabetes Studies
29 mai 2013 08h30 HE
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - May 29, 2013) - Nuvilex, Inc. (OTCQB: NVLX) and its medical marijuana subsidiary, Medical Marijuana Sciences, Inc., may have just found a way to work side by side in an...
Nuvilex, Inc. Could Become Significant Player in the Oncology Arena With Successful Phase III Trials
22 mai 2013 08h30 HE
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - May 22, 2013) - Nuvilex, Inc. (OTCQB: NVLX) is a diamond in the rough in the truest sense. Currently shares of the Silver Spring, Maryland, biotechnology firm can...
Nuvilex, Inc. Cell Encapsulation Could Mimic Combination Chemotherapy
15 mai 2013 08h30 HE
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - May 15, 2013) - Nuvilex, Inc. (OTCQB: NVLX) has had its living cell encapsulation or "Cell-in-a-Box" technology tested again and again, and each time it has proven it...
Nuvilex, Inc.'s Dr. Gerald Crabtree Discusses Upcoming Phase III Cancer Trials, Fast Track and Orphan Drug Status
13 mai 2013 08h30 HE
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - May 13, 2013) - Nuvilex, Inc. (OTCQB: NVLX) COO Dr. Gerald Crabtree is no stranger to late stage clinical trials or dealing with blockbuster therapies for cancer...
Nuvilex, Inc. Shows Success Treating Mammary Tumors Using Cell Encapsulation Technology
07 mai 2013 08h30 HE
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - May 7, 2013) - Nuvilex, Inc. (OTCQB: NVLX) should be convincing investors by now that its technology could truly change the face of healthcare. Many know of the...
BUYINS.NET Updates Nuvilex SqueezeTrigger Report
03 mai 2013 09h00 HE
|
Nuvilex, Inc.
NEWPORT BEACH, CA--(Marketwired - May 3, 2013) - BUYINS.NET, http://www.buyins.net, a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity...